# Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

> **NCT07057024** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Etablissement Public de Santé Barthélemy Durand** · enrollment: 120 (estimated)

## Conditions studied

- Psychiatric Disorders (Diagnosis)

## Interventions

- **OTHER:** Clinical and eye movements

## Key facts

- **NCT ID:** NCT07057024
- **Lead sponsor:** Etablissement Public de Santé Barthélemy Durand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-12
- **Primary completion:** 2028-02
- **Final completion:** 2029-02
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07057024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07057024, "Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07057024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*